Mozart Holdco, Inc. - 06 Aug 2026 Form 4 Insider Report for Medline Inc. (MDLN)

Reporting relationship: 10%+ Owner
Issuer ticker: MDLN
Reported as of: 06 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2026, 16:30:12 UTC
Prior SEC filing: 19 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Eric Orsic, as Attorney-in-Fact for James D. Abrams, Secretary

Key filing fact

Mozart Holdco, Inc. filed Form 4 for Medline Inc. (MDLN) on 07 Aug 2026.

Key facts

This page summarizes Mozart Holdco, Inc.'s Form 4 filing for Medline Inc. (MDLN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Aug 2026, 16:30.

Change

Previous filing in this sequence was filed on 19 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002095472 Primary reporting owner

Mozart Holdco, Inc.

Relationship: 10%+ Owner
Address: C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD
Signature: /s/ Eric Orsic, as Attorney-in-Fact for James D. Abrams, Secretary
Signature date: 07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDLN transaction

Class A Common Stock

Conversion of derivative security

Transaction value
Shares: +500,000
Change %: +174%
Price: $0.000000^*
Shares after: 787,648
Date: 06 Aug 2026
Ownership: Direct
Footnotes: F1

MDLN transaction

Class B Common Stock

Other

Transaction value
Shares: -500,000
Change %: -0.21%
Price: $0.000000^*
Shares after: 233,520,656
Date: 06 Aug 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDLN transaction Derivative

Common Units of Medline Holdings, LP

Conversion of derivative security

Transaction value
Shares: -500,000
Change %: -0.21%
Price: $0.000000^*
Shares after: 233,520,656
Date: 06 Aug 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 500,000
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).

Footnote F2

Shares of Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon an exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled.

Footnote F3

Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.